X0306 4 2020-06-18 0 0000722830 IMMUNOMEDICS INC IMMU 0001701815 Aghazadeh Behzad C/O AVORO CAPITAL ADVISORS LLC 110 GREENE STREET, SUITE 800 NEW YORK NY 10012 1 0 1 1 See Remarks 0001633313 Avoro Capital Advisors LLC C/O AVORO CAPITAL ADVISORS LLC 110 GREENE STREET, SUITE 800 NEW YORK NY 10012 1 0 1 1 See Remarks Common Stock, $0.01 par value per share (''Common Stock'') 2020-06-18 4 A 0 3718 0 A 17234 D Common Stock 100000 D Common Stock 26250000 I See footnotes Stock Option (right to buy) 33.62 2020-06-18 4 A 0 6540 0 A 2021-06-18 2030-06-18 Common Stock, par value $0.01 per share 6540 6540 D Such securities are held on behalf of accounts managed by Avoro Capital Advisors LLC (formerly venBio Select Advisor LLC), a Delaware limited liability company (the "Investment Manager") and Avoro Life Sciences Fund LLC (formerly venBio Select Fund LLC), a Delaware limited liability company, a fund managed by the Investment Manager. Behzad Aghazadeh ("Dr. Aghazadeh," and together with the Investment Manager, the "Reporting Persons") serves as the portfolio manager and controlling person of the Investment Manager. The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein. Such grants of restricted stock units ("RSUs") and stock options were made automatically pursuant to the Issuer's compensation policy for non-employee directors as of the date of the Issuer's 2020 annual meeting of stockholders, which occurred on June 18, 2020. Includes RSUs held by Dr. Aghazadeh that represent a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest on the first anniversary of the date of grant, subject to Dr. Aghazadeh's continued service as a director of the Issuer. Includes RSUs held by Dr. Aghazadeh, granted on March 20, 2020. 1/3 of the RSUs vest on each of the first, second and third anniversary of the date of grant, subject to Dr. Aghazadeh's continued service as the Issuer's Executive Chairman. The stock options vest on the first anniversary of the date of grant, subject to Dr. Aghazadeh's continued service as a director of the Issuer. The Investment Manager may be deemed a director by deputization of Immunomedics, Inc. by virtue of the fact that Dr. Aghazadeh currently serves on the board of directors of the Issuer. /s/ Behzad Aghazadeh 2020-06-22 Avoro Capital Advisors LLC, by: /s/ Behzad Aghazadeh, authorized signatory 2020-06-22